Currently out of the existing stock ratings of Shawn Egan, 2 are a BUY (66.67%), 1 are a HOLD (33.33%).

Shawn Egan

Work Performance Price Targets & Ratings Chart

Analyst Shawn Egan works at CITI with a stock forecast success ratio of 100% fulfilled within 108 days on average.

Shawn Egan’s has documented 6 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ARWR, Arrowhead Pharmaceuticals at 19-Sep-2023.

Wall Street Analyst Shawn Egan

Analyst best performing recommendations are on ARWR (ARROWHEAD PHARMACEUTICALS).
The best stock recommendation documented was for ARWR (ARROWHEAD PHARMACEUTICALS) at 11/19/2020. The price target of $90 was fulfilled within 78 days with a profit of $21.08 (30.59%) receiving and performance score of 3.92.

Average potential price target upside

ARWR Arrowhead Pharmaceuticals

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

90

$59.8 (198.01%)

90

18 days ago

0/7 (0%)

$56.8 (171.08%)

Buy

50

$19.8 (65.56%)

50

18 days ago

2/8 (25%)

$16.8 (50.60%)

100

Hold

33

$2.8 (9.27%)

90

5 months 7 days ago

3/3 (100%)

$5.77 (21.19%)

108

Buy

47

$16.8 (55.63%)

80

6 months 18 days ago

6/7 (85.71%)

$19.51 (70.97%)

219

Buy

47

$16.8 (55.63%)

80

6 months 18 days ago

9/10 (90%)

$19.51 (70.97%)

892

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Shawn Egan is most bullish on?

Potential upside of $2.8 has been obtained for ARWR (ARROWHEAD PHARMACEUTICALS)

What Year was the first public recommendation made by Shawn Egan?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?